Literature DB >> 28601848

Longitudinal analysis indicates symptom severity influences immune profile in irritable bowel syndrome.

Chris Mavrangelos1, Melissa A Campaniello1, Jane M Andrews2, Peter A Bampton3, Patrick A Hughes1.   

Abstract

Entities:  

Keywords:  Neuroimmune; T cell proliferation; cytokine; immune activation; irritable bowel syndrome

Mesh：

Substances：

Year:  2017        PMID： 28601848     DOI： 10.1136/gutjnl-2017-314308

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

1.  From psychology to physicality: how nerve growth factor transduces early life stress into gastrointestinal motility disorders later in life.

Authors:  Chi Fung Willis Chow; Sijia Che; Hong-Yan Qin; Hiu Yee Kwan; Zhao-Xiang Bian; Hoi Leong Xavier Wong
Journal:  Cell Cycle       Date:  2019-07-04       Impact factor: 4.534

2.  Gastrointestinal symptoms and healthcare utilization have increased among patients with functional gastrointestinal and motility disorders during the COVID-19 pandemic.

Authors:  John Gubatan; Thomas Zikos; Estelle Spear Bishop; John Wu; Andrés Gottfried; Laren Becker; Aida Habtezion; Leila Neshatian
Journal:  Neurogastroenterol Motil       Date:  2021-08-11       Impact factor: 3.960

Review 3.  A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies.

Authors:  Bruno K Rodiño-Janeiro; María Vicario; Carmen Alonso-Cotoner; Roberto Pascua-García; Javier Santos
Journal:  Adv Ther       Date:  2018-03-01       Impact factor: 3.845

Review 4.  The trace aminergic system: a gender-sensitive therapeutic target for IBS?

Authors:  Lesha Pretorius; Carine Smith
Journal:  J Biomed Sci       Date:  2020-09-28       Impact factor: 8.410
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.